ReviewEuropean journal of nuclear medicine and molecular imaging2021

Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework.

Konstantinos Chiotis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.